Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | # Peptides (by Search Engine): A2 Sequest HT (IgG) | # Peptides (by Search Engine): B2 Sequest HT (Sel1L) | # Peptides (by Search Engine): C2 Sequest HT (WT) | # Peptides (by Search Engine): D2 Sequest HT (HKO) | # PSMs (by Search Engine): A2 Sequest HT (IgG) | # PSMs (by Search Engine): B2 Sequest HT (Sel1L) | # PSMs (by Search Engine): C2 Sequest HT (WT) | # PSMs (by Search Engine): D2 Sequest HT (HKO) | Abundance: F1: Sample, IgG | Abundance: F2: Sample, Sel1L | Abundance: F3: Sample, WT | Abundance: F4: Sample, HKO | Abundances Count: F1: Sample, IgG | Abundances Count: F2: Sample, Sel1L | Abundances Count: F3: Sample, WT | Abundances Count: F4: Sample, HKO | Modifications | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Ensembl Gene ID | Gene Symbol | Chromosome | Reactome Pathways | KEGG Pathways | # Razor Peptides |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High | Q13561 | Dynactin subunit 2 OS=Homo sapiens OX=9606 GN=DCTN2 PE=1 SV=4 | 0 | 4.565 | 5 | 2 | 5 | 2 | 401 | 44.2 | 5.21 | 2 | 1 | 1 | 3 | 1 | 1 | 877943.5625 | 148029.6563 | 251459.3594 | 125712.9844 | 2 | 1 | 1 | 1 | cell organization and biogenesis;cell proliferation;regulation of biological process;transport | chromosome;cytoplasm;cytoskeleton;cytosol;membrane | catalytic activity;motor activity;protein binding | Pf04912 | 10540 | ENSG00000175203.15 | DCTN2 | 12 | COPI-independent Golgi-to-ER retrograde traffic; Regulation of PLK1 Activity at G2/M Transition; AURKA Activation by TPX2; Anchoring of the basal body to the plasma membrane; Recruitment of NuMA to mitotic centrosomes; Recruitment of mitotic centrosome proteins and complexes; Loss of Nlp from mitotic centrosomes; COPI-mediated anterograde transport; MHC class II antigen presentation; HSP90 chaperone cycle for steroid hormone receptors (SHR) | Huntington's disease; Vasopressin-regulated water reabsorption | 0 |